Clinical Trials Browser

Withdrawn × Observational × enzalutamide × Clear all

NCT03325127 2018-10-31

Outcomes of mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone or Enzalutamide- A Chart Review Study

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant